135 related articles for article (PubMed ID: 11943852)
1. Analysis of structure and function relationships of an autoantigenic peptide of insulin bound to H-2K(d) that stimulates CD8 T cells in insulin-dependent diabetes mellitus.
Wong FS; Moustakas AK; Wen L; Papadopoulos GK; Janeway CA
Proc Natl Acad Sci U S A; 2002 Apr; 99(8):5551-6. PubMed ID: 11943852
[TBL] [Abstract][Full Text] [Related]
2. Functional inhibition related to structure of a highly potent insulin-specific CD8 T cell clone using altered peptide ligands.
Petrich de Marquesini LG; Moustakas AK; Thomas IJ; Wen L; Papadopoulos GK; Wong FS
Eur J Immunol; 2008 Jan; 38(1):240-9. PubMed ID: 18157812
[TBL] [Abstract][Full Text] [Related]
3. Adoptive Transfer of mRNA-Transfected T Cells Redirected against Diabetogenic CD8 T Cells Can Prevent Diabetes.
Fishman S; Lewis MD; Siew LK; De Leenheer E; Kakabadse D; Davies J; Ziv D; Margalit A; Karin N; Gross G; Wong FS
Mol Ther; 2017 Feb; 25(2):456-464. PubMed ID: 28109957
[TBL] [Abstract][Full Text] [Related]
4. T cell receptor (TCR) recognition of MHC class I variants: intermolecular second-site reversion provides evidence for peptide/MHC conformational variation.
Dyall R; Fremont DH; Jameson SC; Nikolić-Zugić J
J Exp Med; 1996 Jul; 184(1):253-8. PubMed ID: 8691139
[TBL] [Abstract][Full Text] [Related]
5. Self peptides isolated from MHC glycoproteins of non-obese diabetic mice.
Reich EP; von Grafenstein H; Barlow A; Swenson KE; Williams K; Janeway CA
J Immunol; 1994 Mar; 152(5):2279-88. PubMed ID: 8133041
[TBL] [Abstract][Full Text] [Related]
6. Identification of an MHC class I-restricted autoantigen in type 1 diabetes by screening an organ-specific cDNA library.
Wong FS; Karttunen J; Dumont C; Wen L; Visintin I; Pilip IM; Shastri N; Pamer EG; Janeway CA
Nat Med; 1999 Sep; 5(9):1026-31. PubMed ID: 10470079
[TBL] [Abstract][Full Text] [Related]
7. Immunotargeting of insulin reactive CD8 T cells to prevent diabetes.
Scott GS; Fishman S; Khai Siew L; Margalit A; Chapman S; Chervonsky AV; Wen L; Gross G; Wong FS
J Autoimmun; 2010 Dec; 35(4):390-7. PubMed ID: 20850948
[TBL] [Abstract][Full Text] [Related]
8. Role of alpha3 domain of class I MHC molecules in the activation of high- and low-avidity CD8+ CTLs.
Belyakov IM; Kozlowski S; Mage M; Ahlers JD; Boyd LF; Margulies DH; Berzofsky JA
Int Immunol; 2007 Dec; 19(12):1413-20. PubMed ID: 17981793
[TBL] [Abstract][Full Text] [Related]
9. Tetramer-blocking assay for defining antigen-specific cytotoxic T lymphocytes using peptide-MHC tetramer.
Yokouchi H; Chamoto K; Wakita D; Noguchi D; Yamazaki K; Dosaka-Akita H; Nishimura M; Ikeda H; Nishimura T
Cancer Sci; 2006 Feb; 97(2):148-54. PubMed ID: 16441426
[TBL] [Abstract][Full Text] [Related]
10. Structural and functional characterization of a single-chain peptide-MHC molecule that modulates both naive and activated CD8+ T cells.
Samanta D; Mukherjee G; Ramagopal UA; Chaparro RJ; Nathenson SG; DiLorenzo TP; Almo SC
Proc Natl Acad Sci U S A; 2011 Aug; 108(33):13682-7. PubMed ID: 21825122
[TBL] [Abstract][Full Text] [Related]
11. Predominant occupation of the class I MHC molecule H-2Kwm7 with a single self-peptide suggests a mechanism for its diabetes-protective effect.
Brims DR; Qian J; Jarchum I; Mikesh L; Palmieri E; Ramagopal UA; Malashkevich VN; Chaparro RJ; Lund T; Hattori M; Shabanowitz J; Hunt DF; Nathenson SG; Almo SC; Dilorenzo TP
Int Immunol; 2010 Mar; 22(3):191-203. PubMed ID: 20093428
[TBL] [Abstract][Full Text] [Related]
12. Identification of overlapping epitopes in mutant ras oncogene peptides that activate CD4+ and CD8+ T cell responses.
Abrams SI; Stanziale SF; Lunin SD; Zaremba S; Schlom J
Eur J Immunol; 1996 Feb; 26(2):435-43. PubMed ID: 8617315
[TBL] [Abstract][Full Text] [Related]
13. Disabling an integral CTL epitope allows suppression of autoimmune diabetes by intranasal proinsulin peptide.
Martinez NR; Augstein P; Moustakas AK; Papadopoulos GK; Gregori S; Adorini L; Jackson DC; Harrison LC
J Clin Invest; 2003 May; 111(9):1365-71. PubMed ID: 12727928
[TBL] [Abstract][Full Text] [Related]
14. Raising allo-restricted cytotoxic T lymphocytes by co-culture of murine splenocytes with autologous macrophage bearing the peptide/allo-major histococompatibility complex.
Chen X; Yan Y; Lu S; Weng X; Liang Z; Li J; Zhong M; Tang J; Xiao W; Sun W; Shen G; Wu X
Hum Immunol; 2009 Feb; 70(2):79-84. PubMed ID: 19100802
[TBL] [Abstract][Full Text] [Related]
15. Discovery of low-affinity preproinsulin epitopes and detection of autoreactive CD8 T-cells using combinatorial MHC multimers.
Unger WW; Velthuis J; Abreu JR; Laban S; Quinten E; Kester MG; Reker-Hadrup S; Bakker AH; Duinkerken G; Mulder A; Franken KL; Hilbrands R; Keymeulen B; Peakman M; Ossendorp F; Drijfhout JW; Schumacher TN; Roep BO
J Autoimmun; 2011 Nov; 37(3):151-9. PubMed ID: 21636247
[TBL] [Abstract][Full Text] [Related]
16. Generation of tissue-specific H-2Kd transgenic mice for the study of K(d)-restricted malaria epitope-specific CD8+ T-cell responses in vivo.
Huang J; Li X; Kohno K; Hatano M; Tokuhisa T; Murray PJ; Brocker T; Tsuji M
J Immunol Methods; 2013 Jan; 387(1-2):254-61. PubMed ID: 23142461
[TBL] [Abstract][Full Text] [Related]
17. Beta-cell-cytotoxic CD8+ T cells from nonobese diabetic mice use highly homologous T cell receptor alpha-chain CDR3 sequences.
Santamaria P; Utsugi T; Park BJ; Averill N; Kawazu S; Yoon JW
J Immunol; 1995 Mar; 154(5):2494-503. PubMed ID: 7868915
[TBL] [Abstract][Full Text] [Related]
18. Distortion of the Major Histocompatibility Complex Class I Binding Groove to Accommodate an Insulin-derived 10-Mer Peptide.
Motozono C; Pearson JA; De Leenheer E; Rizkallah PJ; Beck K; Trimby A; Sewell AK; Wong FS; Cole DK
J Biol Chem; 2015 Jul; 290(31):18924-33. PubMed ID: 26085090
[TBL] [Abstract][Full Text] [Related]
19. H-2Dd exploits a four residue peptide binding motif.
Corr M; Boyd LF; Padlan EA; Margulies DH
J Exp Med; 1993 Dec; 178(6):1877-92. PubMed ID: 8245770
[TBL] [Abstract][Full Text] [Related]
20. Epitope specificity, cytokine production profile and diabetogenic activity of insulin-specific T cell clones isolated from NOD mice.
Daniel D; Gill RG; Schloot N; Wegmann D
Eur J Immunol; 1995 Apr; 25(4):1056-62. PubMed ID: 7537670
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
